Company / R&D per Share
Becton Dickinson R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.38
FY2025
5-year range
$4.09 / $4.65
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#10 of 108
Health Care
What the data says
Among 108 Health Care companies, Becton Dickinson is in the top 9% for r&d per share. R&D per Share returned to growth in FY2025 after 3 years of decline, reaching $4.38.
Based on SEC 10-K filings.
4.38 in FY2025 with a 5-year CAGR of +2.2%. Top quartile in the Health Care sector.
Improved from $4.29 to $4.38 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 108This company $4.38 Sector average $2.07
▼
+111.8% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 7.2% year-over-year.
- Ranks #10 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.38 | +7.2% |
| FY2024 | $4.09 | -4.7% |
| FY2023 | $4.29 | -1.9% |
| FY2022 | $4.37 | -6.1% |
| FY2021 | $4.65 | +18.6% |
| FY2020 | $3.93 | +1.6% |
| FY2019 | $3.86 | +1.9% |
| FY2018 | $3.79 | +10.2% |
| FY2017 | $3.44 | -9.5% |
| FY2016 | $3.81 | +25.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026